Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 5, 2018
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
[ Mon, Mar 05th 2018
] - WOPRAI
Fri, March 2, 2018
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
Whit Mayo Maintained (AMED) at Hold with Increased Target to $66 on, Mar 2nd, 2018
Whit Mayo of Baird, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $60 to $66 on, Mar 2nd, 2018.
Whit has made no other calls on AMED in the last 4 months.
There are 2 other peers that have a rating on AMED. Out of the 2 peers that are also analyzing AMED, 1 agrees with Whit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Bill Sutherland of "Benchmark" Downgraded from Strong Buy to Hold on, Thursday, November 9th, 2017
This is the rating of the analyst that currently disagrees with Whit
- Sheryl Skolnick of "Mizuho" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
